An Observational Study of Fungal Biomarkers (MK-0000-089)

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this study is to evaluate the relationship between fungal biomarker levels during anti-fungal therapy and the success of treatment for fungal infection. The primary hypothesis is that over the initial two weeks of anti-fungal therapy, fungal biomarkers from participants with invasive aspergillosis (IA) will be lower for those with a successful clinical outcome compared to those with a failed clinical outcome.

Official Title

A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis

Eligibility Criteria

Ages Eligible for Study: Older than 16 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Is 16 years of age or older - Female is either post-menopausal, surgically sterilized, willing to use 2 adequate methods of birth control, or agrees to abstain from heterosexual activity throughout the study - Female of child bearing potential must have a negative pregnancy test - Male is surgically sterilized, agrees to use an adequate method of contraception, or agrees to abstain from heterosexual activity for the duration of the study - Has possible, probable, or confirmed invasive aspergillosis (IA) - Has had a computed tomography (CT) or magnetic resonance imaging (MRI) scan 72 hours prior to initiation of anti-fungal therapy
Exclusion Criteria:
  1. - Has had hemodialysis using cellulose membrane within 2 weeks of study start


Wes (Janice) Brown
Wes (Janice) Brown
Blood and marrow transplant specialist, Blood and marrow transplant specialist, Infectious disease doctor
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Dora Ho
Dora Ho
Infectious disease doctor
Clinical Professor, Medicine - Infectious Diseases

Contact us to find out if this trial is right for you.


BMT Referrals